dihexa approved pharmaceutical formulation Dihexa, Purity 99+% , 1 Gram Powder CAS 1401708-83-5 Dihexa Peptide Therapy | Memory

Since the most consistent effect of ACh on hippocampal pyramidal neurons appears to be a pronounced membrane depolarization coupled with increased membrane resistance 59

Crizotinib (PF-02341066) as a potent inhibitor of c-Met and ALK received approval for the treatment of patients with locally advanced or metastatic NSCLC that is ALK-positive in 2013 [70]

I got it. Eric Topol: I dont think medicine can ever go there

In phase 3 trials, lecanemab and donanemab slowed clinical decline in early Alzheimers by roughly a quarter to a third over eighteen months, with a known risk of amyloid-related brain swelling and small bleeds